We are live on ! Find out more
ZIG

Zuckerman Investment Group Portfolio holdings

AUM $1.07B
1-Year Est. Return 29.43%
This Fund
S&P 500
This Quarter Est. Return
-0.53%
1 Year Est. Return
+29.43%
3 Year Est. Return
+114.68%
5 Year Est. Return
+137.07%
10 Year Est. Return
+453.18%
AUM
$865M
AUM Growth
-$17.1M
Cap. Flow
+$17.4M
Cap. Flow %
2.01%
Top 10 Hldgs %
38.5%
Holding
152
New
6
Increased
65
Reduced
30
Closed
5

Top Buys

Rank Stock Value
1
CHWY icon
Chewy
CHWY
+$10.3M
2
ULTA icon
Ulta Beauty
ULTA
+$10.1M
3
HSIC icon
Henry Schein
HSIC
+$6.78M
4
HLMN icon
Hillman Solutions
HLMN
+$3.61M
5
OPLN
Openlane
OPLN
+$3.44M

Sector Composition

Rank Sector Weight
1 Industrials 19.82%
2 Consumer Discretionary 19.16%
3 Financials 14.25%
4 Healthcare 14.05%
5 Technology 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
126
Goldman Sachs
GS
$311B
$258K 0.03%
570
IWM icon
127
iShares Russell 2000 ETF
IWM
$83B
$253K 0.03%
1,245
AVGO icon
128
Broadcom
AVGO
$1.99T
$246K 0.03%
1,530
MPC icon
129
Marathon Petroleum
MPC
$91.3B
$243K 0.03%
1,400
PG icon
130
Procter & Gamble
PG
$345B
$242K 0.03%
1,470
+14
+1% +$2.29K
HWC icon
131
Hancock Whitney
HWC
$6.32B
$232K 0.03%
4,848
QCOM icon
132
Qualcomm
QCOM
$171B
$231K 0.03%
+1,159
New +$219K
GMS
133
DELISTED
GMS Inc
GMS
$226K 0.03%
2,800
GSBD icon
134
Goldman Sachs BDC
GSBD
$1.01B
$225K 0.03%
15,000
VTI icon
135
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$225K 0.03%
840
+5
+0.6% +$1.29K
VTRS icon
136
Viatris
VTRS
$20.6B
$213K 0.02%
20,076
NVCR icon
137
NovoCure
NVCR
$1.89B
$206K 0.02%
12,000
RXRX icon
138
Recursion Pharmaceuticals
RXRX
$1.76B
$188K 0.02%
+25,000
New +$218K
AMST icon
139
Amesite
AMST
$6.81M
$180K 0.02%
60,000
+8,564
+17% +$25.5K
RSI icon
140
Rush Street Interactive
RSI
$2.92B
$137K 0.02%
14,250
NAT icon
141
Nordic American Tanker
NAT
$1.33B
$99.5K 0.01%
25,000
CXAIW icon
142
CXApp Inc Warrant
CXAIW
$986K
$99K 0.01%
490,300
+421,300
+611% +$115K
PHK
143
PIMCO High Income Fund
PHK
$869M
$86.8K 0.01%
18,000
CXAI icon
144
CXApp
CXAI
$15.6M
$76.8K 0.01%
38,000
-12,000
-24% -$39.5K
AMLX icon
145
Amylyx Pharmaceuticals
AMLX
$2.43B
$38K ﹤0.01%
+20,000
New +$38.8K
TDUP icon
146
ThredUp
TDUP
$796M
$19.9K ﹤0.01%
11,727
QVCGA
147
DELISTED
QVC Group Inc Series A
QVCGA
$8.15K ﹤0.01%
259
ACN icon
148
Accenture
ACN
$104B
-610
Closed -$211K
CSQ icon
149
Calamos Strategic Total Return Fund
CSQ
$3.33B
-28,000
Closed -$458K
GD icon
150
General Dynamics
GD
$104B
-997
Closed -$282K

Similar funds

Zuckerman Investment Group's Q2 2024 Portfolio in Review

As of Q2 2024, Zuckerman Investment Group held 152 positions worth $865M, down 1.9% from $882M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Zuckerman Investment Group's Q2 2024 filing shows 6 new, 65 increased, 30 reduced and 5 closed positions. Its largest new stake was CME Group: 3,322 shares worth $653K. The largest sale was Vertiv, an estimated $25.4M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Zuckerman Investment Group's largest Q2 2024 buy was CME Group: 3,322 shares worth $653K.
  • Zuckerman Investment Group added most to Chewy in Q2 2024, an estimated $10.3M increase.
  • Zuckerman Investment Group's biggest Q2 2024 reduction was Vertiv, cutting an estimated $25.4M.
  • Zuckerman Investment Group fully exited Calamos Strategic Total Return Fund in Q2 2024, selling an estimated $458K.
  • Zuckerman Investment Group's ten largest holdings make up 38% of its $865M portfolio in Q2 2024.
  • Zuckerman Investment Group opened 6 new positions and closed 5 in Q2 2024.
  • Zuckerman Investment Group's portfolio value fell 1.9% quarter-over-quarter to $865M.

Based on Zuckerman Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.